^
Association details:
Biomarker:PTEN deletion
Cancer:Breast Cancer
Drug:Piqray (alpelisib) (PIK3CA inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
New
Source:
Title:

Convergent loss of PTEN leads to clinical resistance to a PI3Ka inhibitor

Excerpt:
Targeted exome sequencing identified homozygous loss of PTEN in a post-treatment sample of a breast cancer patient who developed resistance to BYL719 after initially experiencing a durable response to therapy.
DOI:
10.1038/nature13948